<article title='Cardiac_glycoside'><paragraph><template><target>refimprove</target><arg name="date">December 2009</arg></template><bold>Cardiac glycosides</bold><extension extension_name='ref'>Singh, B. and Rastogi, R.P. 1970. Cardenolides-glycosides and genins. Phytochemistry 9: 315-331.</extension><space/>are organic compounds containing a glycoside (sugar) that act on the contractile force of the cardiac muscle. Because of their potency in disrupting the function of the heart, most are extremely toxic. These<space/><link><target>glycoside</target><trail>s</trail></link><space/>are found as<space/><link><target>secondary metabolite</target><trail>s</trail></link><space/>in several<space/><link><target>plant</target><trail>s</trail></link>, but also in some insects, such as the<space/><link><target>milkweed butterfly</target><part>milkweed butterflies</part></link>.<space/><link><target>File:Oleandrin.svg</target><part>thumb</part><part>Example of the chemical structure of<space/><link><target>oleandrin</target></link>, a potent toxic cardiac glycoside extracted from the<space/><link><target>Oleander</target></link><space/>bush.</part></link><space/>Chemically, the aglycone [non-sugar] part of cardiac glycoside is a steroidal moiety.</paragraph><heading level='2'>Uses</heading><paragraph>From ancient times, humans have used cardiac-glycoside-containing plants and their crude extracts as arrow coatings, homicidal or suicidal aids, rat poisons, heart tonics, diuretics and emetics. In modern times, purified extracts or synthetic analogues of a few have been adapted for the treatment of<space/><link><target>congestive heart failure</target></link><space/>and cardiac<space/><link><target>arrhythmia</target></link>.</paragraph><paragraph>Therapeutic uses of cardiac glycosides primarily involve the treatment of cardiac failure. Their utility results from an increased<space/><link><target>cardiac output</target></link><space/>by increasing the<space/><link><target>Inotrope</target><part>force of contraction</part></link>. By increasing intracellular calcium as described below, cardiac glycosides increase<space/><link><target>calcium-induced calcium release</target></link><space/>and thus contraction.They also delay depolarization thus decreasing heart rate.</paragraph><paragraph><link><target>Bufalin</target></link>,<space/><link><target>ouabain</target></link><space/>and<space/><link><target>digoxin</target></link><space/>are a few toxic cardiac glycosides. Digoxin from the foxglove plant is used clinically, whereas bufalin and ouabain are used only experimentally due to their extremely high potency.</paragraph><heading level='2'>Pharmacology</heading><paragraph>Normally,<space/><link><target>Na+/K+-ATPase</target><part>sodium-potassium pumps</part></link><space/>in the membrane of cells (in this case,<space/><link><target>cardiac myocytes</target></link>) pump potassium ions in and sodium ions out. Cardiac glycosides inhibit this pump by stabilizing it in the<space/><link><target>E2-P</target></link><space/>transition state, so that sodium cannot be extruded: intracellular sodium concentration therefore increases. A second membrane ion exchanger,<space/><link><target>Sodium-calcium exchanger</target><part>NCX</part></link>, is responsible for 'pumping' calcium ions out of the cell and sodium ions in (3Na/Ca); raised intracellular sodium levels inhibit this pump, so calcium ions are also not extruded and will begin to build up inside the cell, as well.</paragraph><paragraph>Increased cytoplasmic calcium concentrations cause increased calcium uptake into the<space/><link><target>sarcoplasmic reticulum</target></link><space/>(SR) via the<space/><link><target>SERCA</target></link>2 transporter. Raised calcium stores in the SR allow for greater calcium release on stimulation, so the myocyte can achieve faster and more powerful contraction by cross-bridge cycling. The refractory period of the<space/><link><target>Atrioventricular node</target><part>AV node</part></link><space/>is increased, so cardiac glycosides also function to regulate heart rate.</paragraph><paragraph>Binding of cardiac glycoside to<space/><link><target>Na-K ATPase</target></link><space/>is slow, and after binding, intracellular calcium increases gradually. Thus, the action of<space/><link><target>Digoxin</target><part>digitalis</part></link><space/>(even on<space/><link><target>Intravenous</target><part>IV injection</part></link>) is delayed.</paragraph><preblock><preline></preline></preblock><paragraph>Raised extracellular potassium decreases binding of cardiac glycoside to Na-K ATPase. As a consequence, increased toxicity of these drugs is observed in the presence of<space/><link><target>hypokalemia</target></link>.</paragraph><paragraph>If SR calcium stores become too high, some ions are released spontaneously through SR<space/><link><target>ryanodine receptor</target><trail>s</trail></link>. This effect leads initially to<space/><link><target>bigeminy</target></link>: regular<space/><link><target>ectopic beats</target></link><space/>following each ventricular contraction. If higher glycoside doses are given, rhythm is lost and ventricular tachycardia ensues, followed by fibrillation.</paragraph><heading level='2'>Examples</heading><paragraph>Examples of plants producing cardiac glycosides:</paragraph><list type='bullet'><listitem><link><target>Cardenolide</target></link><space/>type:<list type='bullet'><listitem><italics><link><target>Lily of the Valley</target></link><space/>(Convallaria majalis)</italics></listitem><listitem><italics><link><target>Antiaris toxicaria</target></link></italics></listitem><listitem><italics><link><target>Strophanthus</target></link></italics><space/><link><target>ouabain</target></link><space/>g/k/e-strophanthin</listitem><listitem><italics><link><target>Digitalis</target></link><space/>lanata</italics><space/>and<space/><italics>Digitalis purpurea</italics><space/><link><target>digoxin</target></link>,<space/><link><target>digitoxin</target></link></listitem><listitem><italics><link><target>Nerium oleander</target></link></italics><space/>-<space/><link><target>oleandrin</target></link></listitem><listitem><italics><link><target>Asclepias</target></link><space/>sp.</italics></listitem><listitem><italics><link><target>Calotropis gigantea</target></link></italics><extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Wang, Z. N.; Wang, M. Y.; Mei, W. L.; Han, Z.; Dai, H. F.<space/></arg><arg name="title"><space/>A New Cytotoxic Pregnanone from ''Calotropis gigantea''<space/></arg><arg name="journal"><space/>Molecules<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="volume"><space/>13<space/></arg><arg name="issue"><space/>12<space/></arg><arg name="pages"><space/>3033â€“9<space/></arg><arg name="doi"><space/>10.3390/molecules13123033<space/></arg><arg name="pmid"><space/>19052526<space/></arg></template></extension></listitem></list></listitem><listitem><link><target>Bufadienolide</target></link><space/>type:<list type='bullet'><listitem>''<link><target>Drimia maritima</target></link></listitem><listitem><italics><link><target>Kalanchoe daigremontiana</target></link></italics><space/>and other<space/><italics><link><target>Kalanchoe</target></link></italics><space/>species<space/><link><target>daigremontianin</target></link><space/>and others</listitem></list></listitem></list><paragraph><template><target>Glycosides</target></template><template><target>Cardiac glycosides</target></template></paragraph><heading level='2'>References</heading><paragraph><template><target>Reflist</target></template></paragraph><list type='bullet'><listitem><template><target>cite web</target><arg name="title">Digoxin, oral.</arg><arg name="url">http://galenet.galegroup.com.ezproxy.sfcollege.edu:2048/servlet/HWRC/hits?r</arg><arg name="publisher">RelayHealth</arg><arg name="accessdate">7 May 2012</arg></template></listitem></list><paragraph><template><target>cite web</target><arg name="title">The Electrophysiological Effects of Cardiac Glycosides in Human iPSC-derived Cardiomyocytes and in Guinea Pig Isolated Hearts.</arg><arg name="url">http://web.ebscohost.com.ezproxy.sfcollege.edu:2048/ehost/detail?vid</arg><arg name="publisher">Cell Physiol Biochem</arg><arg name="accessdate">7 May 2012</arg></template></paragraph><heading level='2'>External links</heading><list type='bullet'><listitem><link type='external' href='http://www.people.vcu.edu/~urdesai/car.htm'>VCU School of Pharmacy Cardiac Glycosides</link></listitem></list><paragraph><template><target>DEFAULTSORT:Cardiac Glycoside</target></template><link><target>Category:Pharmaceutics</target></link><link><target>Category:Cardiac glycosides</target><part></part></link></paragraph></article>